| Host: |
Rabbit |
| Applications: |
WB/IF |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-SSX2 (1-188) is suitable for use in Western Blot and Immunofluorescence research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000IF/ICC 1:50-1:200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
SSX2.SSX2B |
| Gene ID: |
6757/727837 |
| Uniprot ID: |
SSX2_HUMAN |
| Immunogen Region: |
1-188 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-188 of human SSX2 (NP_783629.1). |
| Immunogen Sequence: |
MNGDDAFARRPTVGAQIPEK IQKAFDDIAKYFSKEEWEKM KASEKIFYVYMKRKYEAMTK LGFKATLPPFMCNKRAEDFQ GNDLDNDPNRGNQVERPQMT FGRLQGISPKIMPKKPAEEG NDSEEVPEASGPQNDGKELC PPGKPTTSEKIHERSGPKRG EHAWTHRLRERKQLVIYEEI SDPEEDDE |
| Tissue Specificity | Expressed at high level in the testis. Expressed at low level in thyroid. Not detected in tonsil, colon, lung, spleen, prostate, kidney, striated and smooth muscles. Detected in rhabdomyosarcoma and fibrosarcoma cell lines. Not detected in mesenchymal and epithelial cell lines. |
| Function | Could act as a modulator of transcription. |
| Protein Name | Protein Ssx2Cancer/Testis Antigen 5.2Ct5.2Synovial Sarcoma - X Breakpoint 2Tumor Antigen Hom-Mel-40 |
| Cellular Localisation | Nucleus |
| Alternative Antibody Names | Anti-Protein Ssx2 antibodyAnti-Cancer/Testis Antigen 5.2 antibodyAnti-Ct5.2 antibodyAnti-Synovial Sarcoma - X Breakpoint 2 antibodyAnti-Tumor Antigen Hom-Mel-40 antibodyAnti-SSX2 antibodyAnti-SSX2A.SSX2B antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
